The downgrade is based on a number of factors, including OVGH’s large operating losses, negative cash flow and significant recent liquidity declines.
The outlook is negative, reflecting OVGH’s risks of breaching a covenant and debt acceleration or further liquidity decline if operating losses continue at the current pace.
More articles on healthcare finance:
Beauty retailer replaces Tenet on S&P 500
ADR limits & denials: 4 observations from Craneware’s Jeff St. Vrain
Jefferson’s neuroscience institute gets boost with $20M donation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
